Nada Hassanein

Over 3,500 clinical cases of Candida auris, a drug-resistant fungus causing severe illness, have been reported as of August 1. Experts express concern because the yeast resists multiple antifungal drugs and is often seen in healthcare facilities among vulnerable patients. The CDC reports that while case numbers fluctuated compared to last year, the organism remains an emerging threat.

Candida auris, a drug-resistant fungus, has been reported in over half of the states, with 28 states reporting more than 3,500 cases as of Aug. 1. The yeast poses an urgent threat because it resists multiple antifungal drugs and spreads easily among people undergoing complex medical care. Risk factors include severe underlying medical conditions, and symptoms can vary but may involve fever or chills.